Boston Scientific Corporation (BSX) is a competitor of Synergy Pharmaceuticals Inc. (MBA 5-3). It was organized in 1979 and develops, produces, and sells medical devices. The following data (in millions) were adapted from Boston Scientific’s recent financial statements.

1. Compare the preceding data for Boston Scientific with Synergy Pharmaceuticals’ data shown in MBA 5-3.

2. Would the computation of the ratio of cash to monthly cash expenses be meaningful for Boston Scientific?

Transcribed Image Text:

Year 2 Year 1 Net cash flows from operating activities $1,426 $1,182 End of the year cash and cash equivalents 188 196